Professor Onyema Ogbuagu is an internationally recognized leader in infectious diseases and HIV treatment and prevention, known for his prominent contributions to public health and HIV research. As an Associate Professor of Medicine and Pharmacology at Yale School of Medicine, Director of the Yale antivirals and vaccines program, he has been a lead principal investigator on numerous multinational clinical trials, including CAPELLA and the DISCOVER and PURPOSE-2 PrEP trials. In his career,  Professor Ogbuagu has been at the forefront of efforts to develop and implement effective HIV treatment and prevention strategies, including pre-exposure prophylaxis (PrEP) and antiretroviral therapy optimization. 

 

His research and his membership of the US DHHS antiretroviral treatment guidelines panel has informed international guidelines and shaped interventions that are saving lives across high-burden regions, particularly in sub-Saharan Africa and underserved communities globally.

 

With a career defined by scientific rigor and an unrelenting commitment to equity in healthcare, Professor Ogbuagu is also a passionate advocate for reducing disparities in HIV care and prevention domestically and globally. He works closely with global health organizations, policymakers, and grassroots networks to translate cutting-edge science into culturally responsive and context-appropriate solutions.